New Data Reinforces Safety Profile Of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent
PARIS, May 25, 2010 /PRNewswire/ -- Two late-breaking clinical trials presented today at the EuroPCR 2010 conference reinforced the outstanding clinical data supporting Abbott's market-leading XIENCE…